Pasithea Therapeutics Corp. (KTTAW) Cash from Discontinued Operations (2022 - 2023)
Pasithea Therapeutics' (KTTAW) quarterly Cash from Discontinued Operations came in at -$16895.0 in Q4 2023, up 97.8% year-over-year from -$8541.2 in Q4 2022, and down 50.18% quarter-over-quarter from -$11250.0 in Q3 2023.
Powered by 
Analysis
Pasithea Therapeutics Corp. (KTTAW) Cash from Discontinued Operations (2022 - 2023) Analysis & Trends
Pasithea Therapeutics has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting -$16895.0 for Q4 2023.
- In Q4 2023, Cash from Discontinued Operations rose 97.8% year-over-year to -$16895.0; the TTM figure through Dec 2023 stood at -$611278.0 (up 65.98% YoY), while the FY2023 annual figure was -$611278.0, up 65.98% from the prior year.
- Cash from Discontinued Operations came in at -$16895.0 for Q4 2023 at Pasithea Therapeutics, down from -$11250.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of $10698.0 in Q2 2022 to a low of -$769680.0 in Q4 2022.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -16,895.00 |
| Sep 30, 2023 | -11,250.00 |
| Jun 30, 2023 | -399,689.00 |
| Mar 31, 2023 | -183,444.00 |
| Dec 31, 2022 | -769,680.00 |
| Sep 30, 2022 | -626,357.00 |
| Jun 30, 2022 | 10,698.00 |
| Mar 31, 2022 | -411,252.00 |